Adrian Harris

Has grant

Professor of Medical Oncology

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adrian Harris is a Professor of Medical Oncology at the University of Oxford, UK. His research areas encompass breast cancer, lung cancer, and metabolic reprogramming in tumor biology, as evidenced by his recent publications on topics such as hypoxic cell death in breast cancer and the role of autophagy in lung cancer immunotherapy. He is also involved in exploring therapeutic strategies and predictive modeling for cancer prognosis.

Recent Grants

Grant: Close

Enginered synthetic cells for breast cancer therapy

Open Date: 2024-10-01

Close Date: 2025-09-30

Grant: Close

Engineering Synthetic Cells for Cancer Treatment

Open Date: 2023-10-01

Close Date: 2024-09-30

Grant: Close

Targeting hypoxia metabolism and angiogenesis with SimCells for synthetic lethality

Open Date: 2022-10-01

Close Date: 2023-09-30

Grant: Close

Targeting hypoxia metabolism and angiogenesis for synthetic lethality

Open Date: 2021-10-01

Close Date: 2022-09-30

Grant: Close

Inhibition of novel angiogenic pathways and hypoxic metabolic adaptation for synthetic lethality

Open Date: 2020-10-01

Close Date: 2021-09-30

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (10)

Yesim Gokmen-Polar

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adrian Harris

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients

Autophagy Blockage Up-Regulates HLA-Class-I Molecule Expression in Lung Cancer and Enhances Anti-PD-L1 Immunotherapy Efficacy

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model

Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus

Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities

A Rab6 to Rab11 transition is required for dense-core granule and exosome biogenesis in Drosophila secondary cells

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?

75th anniversary of the British Journal of Cancer

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor

Collaborators (10)

Yesim Gokmen-Polar

Daniele Generali

Dominick McIntyre

Michael I. Koukourakis

Russell Leek

Sunil Badve

Geoff Higgins

John Griffiths

Wei Huang

Venugopal Nair

Make your next move.